{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T05:52:01Z","timestamp":1761630721376},"reference-count":23,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,11]]},"DOI":"10.1097\/tp.0000000000000748","type":"journal-article","created":{"date-parts":[[2015,5,9]],"date-time":"2015-05-09T14:33:39Z","timestamp":1431182019000},"page":"2372-2381","source":"Crossref","is-referenced-by-count":24,"title":["Subclinical Lesions and Donor-Specific Antibodies in Kidney Transplant Recipients Receiving Tacrolimus-Based Immunosuppressive Regimen Followed by Early Conversion to Sirolimus"],"prefix":"10.1097","volume":"99","author":[{"given":"Tain\u00e1 Veras","family":"de Sandes-Freitas","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cl\u00e1udia Rosso","family":"Felipe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u00c9rika Fernandes","family":"Campos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Gerbasi","family":"de Lima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Fernanda","family":"Soares","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcello Fabiano","family":"de Franco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wilson Ferreira","family":"Aguiar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H\u00e9lio","family":"Tedesco-Silva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9 Osmar","family":"Medina-Pestana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"issue":"4","key":"R1-25-20210129","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1097\/01.TP.0000128636.70499.6E","article-title":"Calcineurin inhibitor nephrotoxicity: longitudinal assessment by protocol histology.","volume":"78","author":"Nankivell","year":"2004","journal-title":"Transplantation"},{"issue":"25","key":"R2-25-20210129","doi-asserted-by":"crossref","first-page":"2562","DOI":"10.1056\/NEJMoa067411","article-title":"Reduced exposure to calcineurin inhibitors in renal transplantation.","volume":"357","author":"Ekberg","year":"2007","journal-title":"N Engl J Med"},{"issue":"8","key":"R3-25-20210129","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.1111\/j.1600-6143.2009.02726.x","article-title":"Calcineurin inhibitor minimization in the Symphony study: observational results 3 years after transplantation.","volume":"9","author":"Ekberg","year":"2009","journal-title":"Am J Transplant"},{"issue":"11","key":"R4-25-20210129","doi-asserted-by":"crossref","first-page":"2538","DOI":"10.1111\/j.1600-6143.2007.01979.x","article-title":"Lack of benefit of early protocol biopsies in renal transplant patients receiving TAC and MMF: a randomized study.","volume":"7","author":"Rush","year":"2007","journal-title":"Am J Transplant"},{"issue":"1","key":"R5-25-20210129","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1097\/TP.0b013e3182394cb3","article-title":"Impact of early conversion from tacrolimus to sirolimus on chronic allograft changes in kidney recipients on rapid steroid withdrawal.","volume":"93","author":"Heilman","year":"2012","journal-title":"Transplantation"},{"issue":"12","key":"R6-25-20210129","doi-asserted-by":"crossref","first-page":"3155","DOI":"10.1111\/ajt.12481","article-title":"Planned randomized conversion from tacrolimus to sirolimus-based immunosuppressive regimen in de novo kidney transplant recipients.","volume":"13","author":"Silva","year":"2013","journal-title":"Am J Transplant"},{"issue":"11","key":"R7-25-20210129","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.1111\/j.1600-6143.2004.00627.x","article-title":"De novo kidney transplantation without use of calcineurin inhibitors preserves renal structure and function at two years.","volume":"4","author":"Flechner","year":"2004","journal-title":"Am J Transplant"},{"issue":"5","key":"R8-25-20210129","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1111\/j.1600-6143.2011.03961.x","article-title":"Donor-specific HLA antibodies in a cohort comparing everolimus with cyclosporine after kidney transplantation.","volume":"12","author":"Liefeldt","year":"2012","journal-title":"Am J Transplant"},{"issue":"3","key":"R9-25-20210129","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1111\/ctr.12127","article-title":"Incidence of donor-specific antibodies in kidney transplant patients following conversion to an everolimus-based calcineurin inhibitor-free regimen.","volume":"27","author":"Kamar","year":"2013","journal-title":"Clin Transplant"},{"issue":"8","key":"R10-25-20210129","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1111\/tri.12330","article-title":"Conversion to mammalian target of rapamycin inhibitors increases risk of de novo donor-specific antibodies.","volume":"27","author":"Croze","year":"2014","journal-title":"Transpl Int"},{"issue":"4","key":"R11-25-20210129","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1111\/j.1600-6143.2008.02159.x","article-title":"Banff 07 classification of renal allograft pathology: updates and future directions.","volume":"8","author":"Solez","year":"2008","journal-title":"Am J Transplant"},{"issue":"2","key":"R12-25-20210129","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1111\/ajt.12590","article-title":"Banff 2013 meeting report: inclusion of c4d-negative antibody-mediated rejection and antibody-associated arterial lesions.","volume":"14","author":"Haas","year":"2014","journal-title":"Am J Transplant"},{"issue":"Suppl 21","key":"R13-25-20210129","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/j.1399-0012.2009.01105.x","article-title":"Borderline rejection after renal transplantationto treat or not to treat.","volume":"23","author":"Beimler","year":"2009","journal-title":"Clin Transplant"},{"issue":"8","key":"R14-25-20210129","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1111\/tri.12334","article-title":"Predictive factors of allosensitization in renal transplant patients switched from calcineurin to mTOR inhibitors.","volume":"27","author":"Ruiz San Millan","year":"2014","journal-title":"Transpl Int"},{"key":"R15-25-20210129","doi-asserted-by":"crossref","first-page":"228","DOI":"10.3389\/fimmu.2012.00228","article-title":"Akt and mTOR in B cell activation and differentiation.","volume":"3","author":"Limon","year":"2012","journal-title":"Front Immunol"},{"issue":"5","key":"R16-25-20210129","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1111\/j.1600-6143.2009.02612.x","article-title":"Mechanisms of alloantibody production in sensitized renal allograft recipients.","volume":"9","author":"Stegall","year":"2009","journal-title":"Am J Transplant"},{"issue":"4","key":"R17-25-20210129","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1097\/MOT.0b013e32833b9c11","article-title":"The (re)emergence of B cells in organ transplantation.","volume":"15","author":"Stegall","year":"2010","journal-title":"Curr Opin Organ Transplant"},{"issue":"2","key":"R18-25-20210129","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1111\/j.1365-2249.2009.04051.x","article-title":"Calcineurin inhibitors affect B cell antibody responses indirectly by interfering with T cell help.","volume":"159","author":"Heidt","year":"2010","journal-title":"Clin Exp Immunol"},{"issue":"24","key":"R19-25-20210129","doi-asserted-by":"crossref","first-page":"2326","DOI":"10.1056\/NEJMoa020009","article-title":"The natural history of chronic allograft nephropathy.","volume":"349","author":"Nankivell","year":"2003","journal-title":"N Engl J Med"},{"issue":"9","key":"R20-25-20210129","doi-asserted-by":"crossref","first-page":"2114","DOI":"10.1111\/j.1600-6143.2007.01892.x","article-title":"Tacrolimus exposure and evolution of renal allograft histology in the first year after transplantation.","volume":"7","author":"Naesens","year":"2007","journal-title":"Am J Transplant"},{"issue":"8","key":"R21-25-20210129","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1038\/ki.2010.492","article-title":"Mycophenolate mofetil-based immunosuppression with sirolimus in renal transplantation: a randomized, controlled Spare-the-Nephron trial.","volume":"79","author":"Weir","year":"2011","journal-title":"Kidney Int"},{"issue":"12","key":"R22-25-20210129","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.2165\/00002018-200629120-00006","article-title":"Sirolimus-associated proteinuria and renal dysfunction.","volume":"29","author":"Rangan","year":"2006","journal-title":"Drug Saf"},{"issue":"12","key":"R23-25-20210129","doi-asserted-by":"crossref","first-page":"2490","DOI":"10.1681\/ASN.2008091005","article-title":"Significance and management of proteinuria in kidney transplant recipients.","volume":"20","author":"Amer","year":"2009","journal-title":"J Am Soc Nephrol"}],"container-title":["Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/TP.0000000000000748","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T07:19:37Z","timestamp":1620976777000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00007890-201511000-00025"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,11]]},"references-count":23,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2015]]}},"URL":"https:\/\/doi.org\/10.1097\/tp.0000000000000748","relation":{},"ISSN":["0041-1337"],"issn-type":[{"value":"0041-1337","type":"print"}],"subject":[],"published":{"date-parts":[[2015,11]]}}}